Login

Company Executives

Management Team

From Forms 3, 4 and 5 filed in the last 18 months
Officer 2024 pay Source
Micah W Young
EVP, Chief Financial Officer
Title from the Form 4 dated Jun 10, 2026
$8,118,446
Elisabeth A Hellmann
Chief Human Resources Officer
Title from the Form 4 dated Jun 10, 2026
Not reported
Tim Benner
Chief Marketing Officer
Title from the Form 4 dated Jun 10, 2026
Not reported
Paul Hataishi
SVP, Chief Accounting Officer
Title from the Form 4 dated Jun 10, 2026
Not reported
Lisa Hellmann
Chief Human Resources Officer
Not reported
Blair Tripodi
COO, Consumer Division
Title from the Form 4 dated Sep 23, 2025
$6,852,368
Huimin Wang
President, Japan & Asia Pacific
Not reported
Anand Sampath
EVP, Operations
Title from the Form 4 dated Jun 10, 2026
Not reported
Omar Ahmed
CTIO & EVP of Engineering
Title from the Form 4 dated Nov 13, 2025
Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Mar 26, 2025 · updated by the 8-Ks of Aug 19, 2025 and Jun 10, 2026

Directors
3
serving now
Independent
2 of 2
stated in the proxy; 1 not stated
Director Independent 2024 pay Source
Frank McFaden Joined Jun 10, 2026
- -
Robert Chapek Leaving at the meeting
Independent $484,302
Craig Reynolds Leaving at the meeting
Independent $330,408

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

9 disclosed in the proxy filed Mar 26, 2025
Willow Laboratories, Inc.
formerly known as Cercacor Laboratories, Inc.; independent entity spun off from us to our stockholders in 1998
Approximately $20.4 million
2024

Cross-licensing agreement under which we pay minimum royalties; aggregate royalty expense recorded for fiscal 2024

With Willow Laboratories, Inc. Open in proxy
Willow Laboratories, Inc.
formerly known as Cercacor Laboratories, Inc.; independent entity spun off from us to our stockholders in 1998
$2.5 million
2024

Change-in-control payment for licensing of Willow blood glucose monitoring technology, triggered by termination of Mr. Kiani's employment as CEO

With Willow Laboratories, Inc. Open in proxy
Willow Laboratories, Inc.
formerly known as Cercacor Laboratories, Inc.; independent entity spun off from us to our stockholders in 1998
Approximately $0.4 million
2024

Services agreement under which Willow paid us for general and administrative services

With Willow Laboratories, Inc. Open in proxy
Willow Laboratories, Inc.
formerly known as Cercacor Laboratories, Inc.; independent entity spun off from us to our stockholders in 1998
Approximately $1.2 million
2024

Lease of approximately 34,000 square feet of office, research and development space at our Irvine, California facility; we recognized lease income

With Willow Laboratories, Inc. Open in proxy
Mr. Kiani
Chairman of the Masimo Foundation; former CEO
Approximately $2.5 million
fiscal year ended December 28, 2024

Cash contributions made by the Company to the Masimo Foundation

With Masimo Foundation for Ethics, Innovation and Competition in Healthcare Open in proxy
Mr. Kiani
Chairman of the Masimo Foundation; former CEO
Amount not stated
fiscal year ended December 28, 2024

In-kind contributions to the Masimo Foundation, mainly donated administrative services

With Masimo Foundation for Ethics, Innovation and Competition in Healthcare Open in proxy
Mr. Kiani
co-founder and board member of Like Minded Media Ventures
$1.5 million
fiscal year ended December 30, 2023

Marketing service agreement for audiovisual production services and advertising; marketing expenses incurred

With Like Minded Media Ventures Open in proxy
Like Minded Labs (LML)
subsidiary of Like Minded Media Ventures, co-founded by Mr. Kiani
$3.0 million
second quarter of 2021

Software license and professional services agreement; one-time license fee for perpetual license to integrate LML software

With Like Minded Labs (LML) Open in proxy
Directors and executive officers
Amount not stated

Indemnity agreements under which we agree to indemnify directors and executive officers, and related insurance coverage

With the Company Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support